| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8773790 | Kidney International Reports | 2018 | 10 Pages |
Abstract
Oral FC differs from i.v. FO in areas such as less NTBI generation and less induction of oxidative stress. The result indicates potential clinical benefits of oral FC in terms of iron supplementation for renal anemia in HD patients.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Masaaki Nakayama, Yoshihiro Tani, Wan-Jun Zhu, Kimio Watanabe, Keitaro Yokoyama, Masafumi Fukagawa, Takashi Akiba, Myles Wolf, Hideki Hirakata,